preinduction intravenous labetalol for attenuating intubation stress response
DESCRIPTION
PREINDUCTION INTRAVENOUS LABETALOL FOR ATTENUATING INTUBATION STRESS RESPONSE. DR. A. KARTHIK KILPAUK MEDICAL COLLEGE. GUIDE : PROF. DR. P.S.SHANMUGAM, MD, DA HEAD OF DEPARTMENT DEPARTMENT OF ANAESTHESIOLOGY, KILPAUK MEDICAL COLLEGE. - PowerPoint PPT PresentationTRANSCRIPT
PREINDUCTION INTRAVENOUS PREINDUCTION INTRAVENOUS LABETALOL FOR LABETALOL FOR
ATTENUATING INTUBATION ATTENUATING INTUBATION STRESS RESPONSESTRESS RESPONSE
DR. A. KARTHIKDR. A. KARTHIK KILPAUK MEDICAL COLLEGEKILPAUK MEDICAL COLLEGE
GUIDE :GUIDE :
PROF. DR. P.S.SHANMUGAM, MD, DAPROF. DR. P.S.SHANMUGAM, MD, DA HEAD OF DEPARTMENTHEAD OF DEPARTMENT DEPARTMENT OF ANAESTHESIOLOGY,DEPARTMENT OF ANAESTHESIOLOGY, KILPAUK MEDICAL COLLEGE.KILPAUK MEDICAL COLLEGE.
ETHICAL COMMITTEE APPROVAL ETHICAL COMMITTEE APPROVAL OBTAINEDOBTAINED
AIM OF THE STUDYAIM OF THE STUDY
To study and compare the effects of To study and compare the effects of Preinduction intravenous Labetalol at Preinduction intravenous Labetalol at incremental doses of 0.25mg/kg & incremental doses of 0.25mg/kg & 0.5mg/kg in attenuation of intubation 0.5mg/kg in attenuation of intubation stress response in General Anaesthesiastress response in General Anaesthesia
STUDY DESIGNSTUDY DESIGN
• Randomized, Prospective studyRandomized, Prospective study
• Pre study assessment done and consent Pre study assessment done and consent obtained from all the patientsobtained from all the patients
PATIENT SELECTIONPATIENT SELECTION INCLUSION CRITERIA :INCLUSION CRITERIA :
• 45 patients of ASA grade I & II45 patients of ASA grade I & II• Age 18 – 60 yrsAge 18 – 60 yrs• Both sexBoth sex• Elective surgery requiring general Elective surgery requiring general
anaesthesia with endotracheal intubationanaesthesia with endotracheal intubation
EXCLUSION CRITERIAEXCLUSION CRITERIA : :• Patient contraindicated to Patient contraindicated to -blocker; -blocker; eg- eg-
Bronchial Asthma, Peripheral vascular disease, Bronchial Asthma, Peripheral vascular disease, conduction defectsconduction defects
• Hypertensive patients, patients on Anti-HT Hypertensive patients, patients on Anti-HT drugsdrugs
• Systolic BP < 90mmHg; HR< 50/mtSystolic BP < 90mmHg; HR< 50/mt• Having preoperative airway or intubation Having preoperative airway or intubation
problemsproblems• Awake intubation or intubation taking more than Awake intubation or intubation taking more than
20sec or requiring second attempt are excluded20sec or requiring second attempt are excluded
GROUPSGROUPS GROUP A : 15 patients receiving IV Normal GROUP A : 15 patients receiving IV Normal
saline (Placebo) prior to induction (Control)saline (Placebo) prior to induction (Control)
GROUP B : 15 patients receiving Inj. Labetalol GROUP B : 15 patients receiving Inj. Labetalol 0.25mg/kg prior to induction0.25mg/kg prior to induction
GROUP C : 15 patients receiving Inj. Labetalol GROUP C : 15 patients receiving Inj. Labetalol 0.5 mg/kg prior to induction0.5 mg/kg prior to induction
MONITORINGMONITORING
Pulse oximetryPulse oximetry
NIBPNIBP
ECGECG
METHODOLOGYMETHODOLOGY 45 patients randomized into three groups of 15 45 patients randomized into three groups of 15
eacheach Premedication: Given i.m 45 min prior to surgeryPremedication: Given i.m 45 min prior to surgery
Inj. Glycopyrrolate 10ug/kg Inj. Glycopyrrolate 10ug/kg Inj. Pentazocine 0.5mg /kg Inj. Pentazocine 0.5mg /kg
Preoxygenation : 100% O2 for 5 minPreoxygenation : 100% O2 for 5 min Inj Labetalol/ Normal saline given iv 5 min prior Inj Labetalol/ Normal saline given iv 5 min prior
to inductionto induction Induction : Inj.Propofol 2mg/kg ivInduction : Inj.Propofol 2mg/kg iv
NDMR – Inj Rocuronium 0.9mg/Kg NDMR – Inj Rocuronium 0.9mg/Kg iv iv
Patient ventilated with 100% OPatient ventilated with 100% O22 for 3 for 3 minmin
Intubated with appropriate size ET Intubated with appropriate size ET tubetube
Maintained with O2 : N2O – 1:2Maintained with O2 : N2O – 1:2 Volatile inhalational agents used only Volatile inhalational agents used only
10min after intubation10min after intubation
Pulse rate & NIBP were recorded:Pulse rate & NIBP were recorded: PreoperativelyPreoperatively 45 min after premedication 45 min after premedication In the operating table before IV In the operating table before IV
Labetalol/Normal salineLabetalol/Normal saline For every min after IV Labetalol/Normal For every min after IV Labetalol/Normal
saline for 5 minsaline for 5 min After InductionAfter Induction After giving NDMRAfter giving NDMR At laryngoscopyAt laryngoscopy For every 1 min after Endotracheal For every 1 min after Endotracheal
intubation for 10minintubation for 10min
Labetalol — Labetalol — MechanismMechanism
Competitive, selective Competitive, selective 11 and non-selective and non-selective -blocker-blocker > > blocking potency oral is 3:1, blocking potency oral is 3:1,
iv is 7:1 iv is 7:1 It has intrinisic partial B2 It has intrinisic partial B2
agonistic activity hence causes agonistic activity hence causes vasodilationvasodilation
Onset: 5-10 minOnset: 5-10 min Duration of action: 3-6hrsDuration of action: 3-6hrs T1/2 – 5-8hrsT1/2 – 5-8hrs
CVS Effects CVS Effects Decrease SVR leading to decrease in BP is by Decrease SVR leading to decrease in BP is by
alpha -1 blockade alpha -1 blockade Vasodilation also produced by partial B2 agonist Vasodilation also produced by partial B2 agonist
activityactivity Reflex tachycardia due to peripheral vasodilation Reflex tachycardia due to peripheral vasodilation
is attenuated by B blockadeis attenuated by B blockade Cardiac output remains unchangedCardiac output remains unchanged Presynaptic alpha-2 receptors are spared- hence Presynaptic alpha-2 receptors are spared- hence
release of Norepinephrine is intact, which release of Norepinephrine is intact, which inhibits further release of catecholamine (Neg inhibits further release of catecholamine (Neg feedback mech) feedback mech)
Adverse effectsAdverse effects Orthostatic hypotensionOrthostatic hypotension BronchospasmBronchospasm Others- CCF, bradycardia, Heart Others- CCF, bradycardia, Heart
blockblock Increased plasma aminotransferaseIncreased plasma aminotransferase Paresthesia – scalp tinglingParesthesia – scalp tingling Urinary retentionUrinary retention
STATISTICAL ANALYSISSTATISTICAL ANALYSIS
STATISTICAL TEST STATISTICAL TEST USEDUSED
ANOVA testANOVA test F testF test If significance is there, then If significance is there, then
subjected to Post Hoc Testsubjected to Post Hoc Test
ANALYSIS OF AGE ANALYSIS OF AGE AMONG THE GROUPSAMONG THE GROUPS
P value = 0.834, which is not significantP value = 0.834, which is not significant
AGE
95% Confidence Interval for Mean
Group N Mean Std. Deviation
Std. Error
Lower Bound
Upper Bound
A 15 38.47 11.556 2.984 32.07 44.87
B 15 36.00 11.091 2.864 29.86 42.14
C 15 37.87 12.293 3.174 31.06 44.67
COMPARISON OF PREOP COMPARISON OF PREOP HEART RATE AMONG THE HEART RATE AMONG THE
GROUPSGROUPS
PRE OP HR
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 85.87 12.677 3.273 78.85 92.89
B 15 86.87 8.823 2.278 81.98 91.75
C 15 85.13 11.250 2.905 78.90 91.36
P=0.911 , NOT SIGNIFICANT
COMPARISON OF PREOP COMPARISON OF PREOP SYSTOLIC BP AMONG THE SYSTOLIC BP AMONG THE
GROUPSGROUPS PRE OP SBP
95% Confidence Interval for Mean
N Mean Std. Deviation
Std. Error
Lower Bound
Upper Bound
A 15 120.47 8.442 2.180 115.79 125.14
B 15 124.40 12.933 3.339 117.24 131.56
C 15 124.67 13.911 3.592 116.96 132.37
P=0.567 , NOT SIGNIFICANT
COMPARISON OF PREOP COMPARISON OF PREOP DIASTOLIC BP AMONG THE DIASTOLIC BP AMONG THE
GROUPSGROUPS PRE OP DBP
95% Confidence Interval for Mean
N Mean Std. Deviation
Std. Error
Lower Bound
Upper Bound
A 15 79.33 6.287 1.623 75.85 82.81 B 15 80.13 8.684 2.242 75.32 84.94 C 15 82.87 7.717 1.993 78.59 87.14
P=0.420 , NOT SIGNIFICANT
COMPARISON OF HR AFTER COMPARISON OF HR AFTER 5MIN OF LABETALOL IV5MIN OF LABETALOL IV
5 MINUTES STUDY HR
95% Confidence Interval for Mean
N Mean Std. DeviationStd. Error Lower Bound Upper Bound
A 15 87.47 13.799 3.563 79.83 95.11 B 15 81.67 12.793 3.303 74.58 88.75 C 15 81.20 13.497 3.485 73.73 88.67
P=0.368 , NOT SIGNIFICANT
COMPARISON OF SYSTOLIC COMPARISON OF SYSTOLIC BP AFTER 5MIN OF BP AFTER 5MIN OF
LABETALOL IVLABETALOL IV
5 MINUTES STUDY SBP
95% Confidence Interval for Mean
N Mean Std. Deviation
Std. Error
Lower Bound
Upper Bound
A 15 121.47 8.782 2.268 116.60 126.33 B 15 122.00 12.012 3.101 115.35 128.65 C 15 122.13 12.432 3.210 115.25 129.02
P=0.985 , NOT SIGNIFICANT
COMPARISON OF DIASTOLIC COMPARISON OF DIASTOLIC BP AFTER 5MIN OF BP AFTER 5MIN OF
LABETALOL IVLABETALOL IV 5 MINUTE STUDY DBP
95% Confidence Interval for Mean
N Mean Std. DeviationStd. Error Lower Bound Upper Bound
A 15 79.27 6.076 1.569 75.90 82.63 B 15 73.40 9.635 2.488 68.06 78.74 C 15 71.80 9.445 2.180 66.12 76.48
P=0.105, NOT SIGNIFICANT
COMPARISON OF HEART COMPARISON OF HEART RATE AT LARYNGOSCOPYRATE AT LARYNGOSCOPY
HR AT SCOPY
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 109.00 13.810 3.566 101.35 116.65
B 15 89.33 13.839 3.573 81.67 97.00
C 15 88.13 14.272 3.685 80.23 96.04
P=0.000 , SIGNIFICANT
By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.815)
COMPARISON OF HEART COMPARISON OF HEART RATE AT 1 MIN AFTER RATE AT 1 MIN AFTER
INTUBATIONINTUBATION SCOPY OF 1 MINUTE HR
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 104.00 11.946 3.085 97.38 110.62
B 15 87.20 13.262 3.424 79.86 94.54
C 15 86.27 15.285 3.947 77.80 94.73
P=0.001, SIGNIFICANT
By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.851)
COMPARISON OF HEART COMPARISON OF HEART RATE AT 3 MIN AFTER RATE AT 3 MIN AFTER
INTUBATIONINTUBATION SCOPY OF 3 MINUTES HR
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 96.67 11.592 2.993 90.25 103.09
B 15 83.13 13.081 3.378 75.89 90.38
C 15 83.07 13.488 3.483 75.60 90.54
P=0.007, SIGNIFICANT
By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.989)
COMPARISON OF HEART COMPARISON OF HEART RATE AT 5 MIN AFTER RATE AT 5 MIN AFTER
INTUBATIONINTUBATION SCOPY OF 5 MINUTES HR
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 92.93 11.985 3.094 86.30 99.57
B 15 81.93 12.981 3.352 74.74 89.12
C 15 80.93 12.355 3.190 74.09 87.78
P=0.02, SIGNIFICANTBy Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.827)
COMPARISON OF HEART COMPARISON OF HEART RATE AT 10 MIN AFTER RATE AT 10 MIN AFTER
INTUBATIONINTUBATION
P=0.022, SIGNIFICANT
By Post Hoc Test: There was a difference between the control & Labetalol groups, but there was no significant difference between the two Labetalol groups (P=0.805)
SCOPY OF 10 MINUTES HR
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 90.40 12.385 3.198 83.54 97.26
B 15 80.27 11.139 2.876 74.10 86.43
C 15 79.20 11.639 3.005 72.75 85.65
COMPARISON OF COMPARISON OF SYSTOLIC BP AT SYSTOLIC BP AT LARYNGOSCOPYLARYNGOSCOPY
SBP AT LARYNGOSCOPY
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 143.47 10.148 2.620 137.85 149.09
B 15 139.07 14.709 3.798 130.92 147.21
C 15 134.00 16.248 4.195 125.00 143.00
P=0.189 , NOT SIGNIFICANT
COMPARISON OF SYSTOLIC COMPARISON OF SYSTOLIC BP AT 1 MIN AFTER BP AT 1 MIN AFTER
INTUBATIONINTUBATION SCOPY 1 MINUTES SBP
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 137.07 6.006 1.551 133.74 140.39
B 15 134.07 14.782 3.817 125.88 142.25
C 15 128.60 16.137 4.167 119.66 137.54
P=0.212, NOT SIGNIFICANT
COMPARISON OF SYSTOLIC COMPARISON OF SYSTOLIC BP AT 3 MIN AFTER BP AT 3 MIN AFTER
INTUBATIONINTUBATION
SCOPY 3 MINUTES SBP
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 130.07 4.448 1.148 127.60 132.53
B 15 125.20 15.232 3.933 116.76 133.64
C 15 122.07 13.614 3.515 114.53 129.61
P=0.200, NOT SIGNIFICANT
COMPARISON OF SYSTOLIC COMPARISON OF SYSTOLIC BP AT 5 MIN AFTER BP AT 5 MIN AFTER
INTUBATIONINTUBATION
SCOPY 5 MINUTES SBP
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 128.47 4.470 1.154 125.99 130.94
B 15 122.07 12.881 3.326 114.93 129.20
C 15 117.53 11.667 3.012 111.07 123.99
P=0.021, SIGNIFICANT
COMPARISON OF SYSTOLIC COMPARISON OF SYSTOLIC BP AT 10 MIN AFTER BP AT 10 MIN AFTER
INTUBATIONINTUBATION
SCOPY 10 MINUTES SBP
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 126.60 5.356 1.383 123.63 129.57
B 15 121.07 13.123 3.388 113.80 128.33
C 15 117.20 11.162 2.882 111.02 123.38
P=0.051, NOT SIGNIFICANT
COMPARISON OF COMPARISON OF DIASTOLIC BP AT DIASTOLIC BP AT LARYNGOSCOPYLARYNGOSCOPY
DBP AT LARYNGOSCOPY
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 92.40 7.908 2.042 88.02 96.78 B 15 85.27 12.959 3.346 78.09 88.44 C 15 83.87 9.970 2.574 76.35 87.39
P=0.039 , SIGNIFICANT
COMPARISON OF DIASTOLIC COMPARISON OF DIASTOLIC BP AT 1 MIN AFTER BP AT 1 MIN AFTER
INTUBATIONINTUBATION SCOPY 1 MINUTES DBP
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 88.67 6.377 1.647 85.14 92.20 B 15 80.33 11.437 2.953 74.00 86.67 C 15 80.65 9.453 2.441 76.70 85.17
P=0.023, SIGNIFICANT
COMPARISON OF DIASTOLIC COMPARISON OF DIASTOLIC BP AT 3 MIN AFTER BP AT 3 MIN AFTER
INTUBATIONINTUBATION SCOPY 3 MINUTES DBP
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 84.80 6.472 1.671 81.22 88.38
B 15 77.27 11.455 2.958 70.92 83.61
C 15 78.93 9.869 2.032 73.58 83.29
P=0.063, NOT SIGNIFICANT
COMPARISON OF DIASTOLIC COMPARISON OF DIASTOLIC BP AT 5 MIN AFTER BP AT 5 MIN AFTER
INTUBATIONINTUBATION
SCOPY 5 MINUTES DBP
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 82.40 5.816 1.502 79.18 85.62
B 15 74.40 10.782 2.784 68.43 80.37
C 15 71.87 8.624 1.968 67.64 76.09
P=0.028, SIGNIFICANT
COMPARISON OF DIASTOLIC COMPARISON OF DIASTOLIC BP AT 10 MIN AFTER BP AT 10 MIN AFTER
INTUBATIONINTUBATION
SCOPY 10 MINUTES DBP
95% Confidence Interval for Mean
N Mean Std. Deviation Std. Error Lower Bound Upper Bound
A 15 80.87 6.739 1.740 77.13 84.60
B 15 72.47 10.501 2.711 66.65 78.28
C 15 71.60 9.152 2.105 65.29 76.31
P=0.021, SIGNIFICANT
CONCLUSIONCONCLUSION Heart Rate: Heart Rate:
Preinduction iv labetalol decreased the heart Preinduction iv labetalol decreased the heart rate prior to induction in the Labetalol groups rate prior to induction in the Labetalol groups (decrease in Group C>Group B>Group A) at 5 (decrease in Group C>Group B>Group A) at 5 min after labetalol injection. But it is not min after labetalol injection. But it is not statistically significantstatistically significant
Attenuation of heart rate at Laryngoscopy, at Attenuation of heart rate at Laryngoscopy, at 1min, 3min, 5min, 7min & 10min after intubation 1min, 3min, 5min, 7min & 10min after intubation (decrease in Group C>Group B>Group A) is (decrease in Group C>Group B>Group A) is statistically significant.statistically significant.
Preop HR was achieved at 1 min after intubationPreop HR was achieved at 1 min after intubation
HEART RATEHEART RATEANOVA
F Sig.
SCOPY (0 MINUTE) HR Between Groups 10.543 .000
SCOPY OF 1 MINUTE HR Between Groups 8.116 .001
SCOPY OF 3 MINUTES HR Between Groups 5.664 .007
SCOPY OF 5 MINUTES HR Between Groups 4.292 .020
SCOPY OF 7 MINUTES HR Between Groups 4.195 .022
SCOPY OF 10 MINUTES HR Between Groups 4.164 .022
CONCLUSIONCONCLUSION Systolic BP: Systolic BP:
Preinduction iv labetalol had no change in the Preinduction iv labetalol had no change in the systolic BP prior to induction in the Labetalol systolic BP prior to induction in the Labetalol groups at 5 min after labetalol injection. groups at 5 min after labetalol injection.
Attenuation of Systolic BP at Laryngoscopy, at Attenuation of Systolic BP at Laryngoscopy, at 1min, 3min, 7min & 10min after intubation is 1min, 3min, 7min & 10min after intubation is not statistically significant (decrease in Group not statistically significant (decrease in Group C>Group B>Group A)C>Group B>Group A)
Preop systolic BP value was reached 3-5min Preop systolic BP value was reached 3-5min after intubationafter intubation
SYSTOLIC BPSYSTOLIC BPANOVA
F Sig.
SCOPY 0 MINUTES SBP Between Groups 1.731 .189
SCOPY 1 MINUTES SBP Between Groups 1.610 .212
SCOPY 3 MINUTES SBP Between Groups 1.673 .200
SCOPY 5 MINUTES SBP Between Groups 4.217 .021
SCOPY 7 MINUTES SBP Between Groups 3.086 .056
SCOPY 10 MINUTES SBP Between Groups 3.226 .051
CONCLUSIONCONCLUSION Diastolic BP: Diastolic BP:
Preinduction iv labetalol decreased the diastolic Preinduction iv labetalol decreased the diastolic BP prior to induction in the Labetalol groups BP prior to induction in the Labetalol groups (decrease in Group C>Group B>Group A) at 5 min (decrease in Group C>Group B>Group A) at 5 min after labetalol injection. But it is not statistically after labetalol injection. But it is not statistically significantsignificant
Attenuation of Diastolic BP at Laryngoscopy, at Attenuation of Diastolic BP at Laryngoscopy, at 1min, 5min, 7min & 10min after intubation is 1min, 5min, 7min & 10min after intubation is statistically significant (decrease in Group statistically significant (decrease in Group C>Group B>Group A)C>Group B>Group A)
Preop diastolic BP was reached 2-3min after Preop diastolic BP was reached 2-3min after intubationintubation
DIASTOLIC BPDIASTOLIC BPANOVA
F Sig.
SCOPY 0 MINUTE DBP Between Groups 2.154 .039
SCOPY 1 MINUTES DBP Between Groups 4.126 .023
SCOPY 5 MINUTES DBP Between Groups 3.896 .028
SCOPY 7 MINUTES DBP Between Groups 3.252 .049
SCOPY 10 MINUTES DBP Between Groups 4.236 .021
CONCLUSIONCONCLUSION Both Group B & C showed attenuation of Both Group B & C showed attenuation of
intubation stress response(HR, Diastolic intubation stress response(HR, Diastolic BP & to a certain extent Systolic BP) BP & to a certain extent Systolic BP) compared to control group (Group A), compared to control group (Group A), but the difference between the two but the difference between the two Labetalol groups is very less & not Labetalol groups is very less & not statistically significant. Hence statistically significant. Hence Labetalol Labetalol 0.25mg/kg 0.25mg/kg is quiet effective & is quiet effective & economical in attenuating stress economical in attenuating stress response.response.